The way hospitals treat bowel cancer varies significantly across Yorkshire. The Bowel Cancer Improvement Programme, funded by Yorkshire Cancer Research, assesses these differences and works with individual hospitals to specifically address any areas of weakness. It also seeks to implement and accelerate the introduction of the latest advances.
We are in pursuit of the gold-standard for bowel cancer treatment throughout Yorkshire. By improving outcomes for people with bowel cancer, this study could save as many as 300 lives each year.
While new cancer treatments are vital, ensuring everyone receives the same level of high-quality care is also hugely important. This ten-year study is designed to understand where differences in treatment occur, which treatments give the best results and how they can be delivered across the region. The research team analyses existing NHS data and uses additional information received from people with bowel cancer who have been cared for by NHS Trusts across the region.
It is essential that hospitals in Yorkshire are able to learn from each other and adopt the most successful ways of working so that areas for improvement can be identified and the necessary changes implemented.
Currently, there is a 'postcode lottery' in terms of treatment for bowel cancer. Yorkshire Cancer Research believes that, regardless of where someone lives in Yorkshire, they should be able to access the very best treatment. This study aims to make this a reality by working closely with doctors and people receiving treatment to understand where the biggest issues are and to take steps to tackle these at a local level. Ultimately, this will result in treatment improvements and a greater likelihood of all bowel cancer patients receiving gold standard care, irrespective of where they live and where they are treated.
Bowel Cancer Improvement Programme
Professor Philip Quirke – University of Leeds